DDB participates in INCB training to counter dangerous drugs trafficking

The Dangerous Drugs Board (DDB) attended the Project Ion Incident Communication System (IONICS) and Precursors Incident System (PICS) workshop, last 17-18 January 2019 in Bangkok, Thailand.

Read more ...

Anti-drug campaign, not just about law enforcement – DDB

The Dangerous Drugs Board underscores that the country’s anti-drug campaign is based on a holistic, comprehensive and balanced approach.

Read more ...

DDB gathers ASEAN Duty – Bearers for the Convention on Drug Abuse Prevention Education

The 1st ASEAN Convention on Drug Abuse Prevention Education begins today at the Crowne Plaza Hotel, Quezon City.

Read more ...

DDB leads nation in Drug Abuse Prevention and Control week celebration

The Dangerous Drugs Board (DDB), the country’s lead agency on drug abuse prevention and control, spearheads the celebration of the Drug Abuse Prevention and Control or DAPC Week from November 12-16, 2018.

Read more ...

DDB welcomes signing of the Philippine Anti-Illegal Drugs Strategy Executive Order

The Dangerous Drugs Board welcomes the issuance of the Executive Order institutionalizing the implementation of the Philippine Anti-Illegal Drugs Strategy or the PADS. The policy directive was signed by President Rodrigo Roa Duterte on 29 October 2018.

Read more ...

Philippines participation in the 6th ASEAN Ministerial Meeting on Drug Matters highlight government’s efforts in addressing the drug problem

Speaking in the presence of ASEAN Ministers, DDB Chairman (Secretary) Catalino Cuy emphasized the Philippine Government’s approach in addressing the drug problem. In a 15-minute speech delivered by the top official in Hanoi (Vietnam), it was highlighted that the Philippine Government uses a comprehensive and balanced approach on drug abuse prevention and control.

Read more ...

Drug testing, mandatory for local elected officials

In line with the filing of candidacy for the 2019 elections, the Dangerous Drugs Board (DDB) encourages the aspiring candidates to submit to the mandatory drug testing once they become elected as local public officials.

Read more ...

In continuous pursuit of its priorities, DDB welcomes recent pronouncements from the United Nations

Noting the recent statement of United Nations Secretary General Antonio Guterres on the need for government to act on drug addiction, the Dangerous Drugs Board emphasizes its strategy to address the Philippines’ drug problem through a balanced and holistic approach.

Read more ...

DDB Statement on the Ambush of PDEA Agents in Lanao del Sur

The Dangerous Drugs Board (DDB) condemns the ambush-slay of five agents of the Philippine Drug Enforcement Agency (PDEA) in Kapai, Lanao del Sur. In solidarity with the PDEA leadership, DDB Chairman (Secretary) Catalino Cuy expressed his great concern and deepest sympathy over the incident.

Read more ...

(Facility Based)
CY 2011

AGE : Mean age of 29 years
SEX : Ratio of male to female 9:1
CIVIL STATUS : Single 51.94%
STATUS OF EMPLOYMENT : Unemployed 35.16%
ECONOMIC STATUS : Average Monthly Family Income Php 15,818.10
PLACE OF RESIDENCE : Urban (Specifically NCR 48.42%)
DURATION OF DRUG - TAKING : More than six (6) years
NATURE OF DRUG - TAKING : Poly drug use**
                                         Methamphetamine Hydrochloride (Shabu)
                                         Cannabis (Marijuana)
                                         Inhalants (Contact Cement Adhesive)

*Residential and Out-Patient Facilities
**Poly drug users - abuse of more than one (1) drug

(Facility Based)*
CY 2011

                                                   MALE                FEMALE         GRAND TOTAL
NEW ADMISSION 2,148  70.66  246  8.09  2,394  78.75 
RE-ADMISSION  410 13.49  15  0.49  425  13.98 
OUT-PATIENT  190  6.25  31  1.02  221  7.27 
TOTAL  2,748  90.39  292  9.61  3,040  100.00 

* Total Reported Cases from Residential and Out-Patient Facilities


       For the year 2011, thirty (30) residential treatment and three (3) outpatient facilities reported to the Integrated Drug Abuse Data and Information Network (IDADIN). These facilities reported a total admission of 3,040 drug cases. Of this number, 78.75% or 2,394 were new admission, 13.98% or 425 were relapse cases and 7.27% or 221 were referrals from outpatient facilities.

       A 10.75% increase was recorded from previous year. The increase may be attributable to the intensified advocacy program done by the government to convince families that those who have drug problems need to undergo treatment and rehabilitation. On the other hand, the increase on the arrests of users based on the intensified operations conducted by the law enforcement on pushers/users
may also have contributed to the increase of admission in the treatment and rehabilitation facilities

* Reported Cases from Residential and Out-Patient Facilities

(Facility Based)*
CY 2011
DRUGS USED / ABUSED NEW ADMISSION RE-ADMISSION OUT-PATIENT GRAND TOTAL % based on the total number of responses (3,692) % based on the total number of admissions (3,040)
1. Methamphetamine Hydrochloride(Shabu) 1,812 380 116 2,308 62.51 75.92
2. Cannabis (Marijuana) 767 136 89 992 26.87 32.63
3. Inhalants (Contact Cement, Adhesive) 156 10 9 175 4.74 5.76
4. Benzodiazepines (Diazepam) 41 14 3 58 1.57 1.91
5. Cocaine 37 13   50 1.35 1.64
6. Solvent 16   15 31 0.84 1.02
7. Nalbuphine Hydrochloride (Nubain) 25 3   28 0.76 0.92
8. MDMA (Ecstasy) 18 9   27 0.73 0.89

*  Reported Cases from Residential and Out-Patient Facilities